ReLAVRA+: Leading the fight against antimicrobial resistance in Latin America and the Caribbean

This brochure provides an overview of the work of the Latin American and Caribbean Network for Antimicrobial Resistance Surveillance (ReLAVRA+). Since its creation in 1996, ReLAVRA+ has grown to include 33 countries, strengthening laboratory capacity, improving AMR detection, and fostering collaboration across the Region. The brochure highlights key milestones in ReLAVRA+’s evolution, from expanding its membership to the Caribbean, to launching isolate-level surveillance and fungal pathogen monitoring. It details how the network drives evidence-based decision-making by providing high-quality, timely data and by supporting capacity-building, external quality assessments, and regional data platforms. In a context of rising antimicrobial resistance, ReLAVRA+ is essential for guiding clinical practice, informing national policies, and supporting public health action. Looking ahead, the network is helping countries to advance genomic surveillance, integrate a One Health approach, and leverage AMR data for stronger, more resilient health systems. With solidarity, resilience, and excellence at its core, ReLAVRA+ continues to lead efforts to safeguard effective treatments and promote sustainable health across the Americas.